Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IIOngoingD-0041-2027

Drug recall · October 21, 2026

Sermorelin recall

Why: Lack of process control

Class II: could cause temporary or reversible health problems; serious harm is remote.

The recall

Product

Sermorelin, 1 mg/mL, 10 ml vial, Sterile injectable solution, RX Only, Houston RX LLC, 15430 Vantage Parkway E STE 220, Houston, TX 77032.

Lots / codes

Lot# SER-081726-1-10, Beyond Use Date: 10/01/2026.

Quantity
7 vials
Company
Houston Rx LLC, Houston, TX
Distribution
Nationwide in the USA.
Initiated
September 25, 2026 · Voluntary: Firm initiated
Classified
October 13, 2026
Reported
October 21, 2026
How notified
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Recalled with it (same recall event)

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.